Nicola Jayne Lilliott

Title: Nicola Jayne Lilliott: Innovator in Pharmaceutical Composition

Introduction

Nicola Jayne Lilliott is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. Her work exemplifies the intersection of science and healthcare, aiming to improve patient outcomes through effective treatments.

Latest Patents

Nicola holds a patent for a pharmaceutical composition that includes a thiazolidinedione, such as Compound (I), metformin hydrochloride, and a pharmaceutically acceptable carrier. This composition is designed to ensure that both the thiazolidinedione and metformin hydrochloride are dispersed within their own carriers, enhancing the efficacy of the medication. This innovative approach has the potential to advance therapeutic options in medicine.

Career Highlights

Throughout her career, Nicola has been associated with SmithKline Beecham Corporation, where she has contributed to various research initiatives. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in the industry. With a focus on improving drug delivery systems, she continues to push the boundaries of pharmaceutical science.

Collaborations

Nicola has worked alongside notable colleagues, including Karen Lewis and Donald Colin MacKenzie. These collaborations have fostered a dynamic environment for innovation and have led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Nicola Jayne Lilliott's contributions to pharmaceutical compositions highlight her role as an influential inventor in the healthcare sector. Her innovative work continues to pave the way for advancements in medical treatments, showcasing the importance of research and collaboration in the field.